Hong Kong, China

Kim-hung Lam


 

Average Co-Inventor Count = 9.0

ph-index = 2

Forward Citations = 67(Granted Patents)


Company Filing History:


Years Active: 2013-2016

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Kim-hung Lam in Cancer Treatment

Introduction

Kim-hung Lam is a notable inventor based in Hong Kong, China. He has made significant contributions to the field of cancer treatment through his innovative research and development of new compounds. With a total of two patents to his name, Lam is recognized for his dedication to advancing medical science.

Latest Patents

One of Lam's latest patents is titled "Method of making and administering quinoline derivatives as anti-cancer agents." This invention focuses on methods for preparing quinoline derivative compounds and administering them in the treatment of both solid and non-solid tumors, particularly liver cancer. Another significant patent is "Water-soluble polymer-based cantharimides as potentially selective anti-tumor agents." This patent describes a cantharimide compound that may include a specific backbone structure, with various components that can be independently selected from a range of chemical groups.

Career Highlights

Kim-hung Lam is affiliated with The Hong Kong Polytechnic University, where he conducts his research and development work. His position at this esteemed institution allows him to collaborate with other experts in the field and contribute to groundbreaking advancements in cancer treatment.

Collaborations

Some of Lam's notable coworkers include Johnny Cheuk-on Tang and Albert Sun-chi Chan. Their collaborative efforts enhance the research environment and foster innovation in their respective projects.

Conclusion

Kim-hung Lam's contributions to cancer treatment through his innovative patents demonstrate his commitment to improving medical outcomes. His work continues to inspire advancements in the field of oncology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…